BPTHOTCPharmaceutical PreparationsFiscal year ends December 31
BIO-PATH HOLDINGS, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.80K
- P/E (TTM)
- –
- Dividend yield
- –
Debt
Borrowings on the balance sheet, Mar 31, 2026
Bio-Path reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Bio-Path's annual report. Trading prices and yields need FINRA TRACE data.